Global “3D Bioprinting Market” (2018 – 2023) Report Provides Overall study of Approximate CAGR, Leading Manufacturers, Key Development, Market Dynamics and SWOT analysis for Key Players. The 3D Bioprinting market is expected to register a CAGR of approximately 22.35% during the forecast period of (2018 – 2023)
3D Bioprinting Market Report Covers Leading Manufacturers: 3D Systems Corp., Aspect Biosystems Ltd, GeSIM GmbH,Bio3D Technologies,BioBots, Inc.,Cyfuse Biomedical KK,Envision TEC GmbH,Organovo Holdings Inc,Rainbow Biosciences LLC,RegenHU SA,Stratasys Ltd,TeVido Biodevices, Inc.,3D Bioprinting Solutions
Get Sample PDF of Report @ https://www.360marketupdates.com/enquiry/request-sample/12883692
The global 3D bioprinting market is expected register a CAGR of 22.35% during the forecast period (2018 – 2023). 3D printer manufacturing companies are working toward building a human tissue for surgical therapy and transplantation. Developments such as this are expected to propel the market for global 3D bioprinting, which is expected to witness a significant growth, owing to technological advancements, government intervention for improving healthcare, and increasing investments in R&D. Global players are increasingly exploring 3D bioprinting as it reduces the risks associated with anesthesia during long surgeries and helps improve healthcare services.
INCREASING PERCENTAGE OF GERIATRIC POPULATION
The percentage of aged population (>65 years) is increasing gradually. It is a strong indicator for the growth of the 3D bioprinter market, as elderly population is more prone toward organ related ailments. Japan has the highest percentage of geriatric population in the world. The market for 3D bioprinters, which is designed for dentistry applications, is expected to witness a good growth rate, more so due to the rising geriatric population. These 3D bioprinters can be used by dentists to create friendlier implants and prosthetics by utilizing the patient’s unique teeth layout and bone scans. Trailing Japan, countries in the western hemisphere have a high percentage of aged population, which is rising continuously, driving the demand for 3D bioprinters.
DRUG DISCOVERY RESEARCH TO GAIN TRACTION OVER THE FORECAST PERIOD
Drug discovery is a highly expensive process, and in most cases, it fails in gaining regulatory clearance. One of the major expenses for a pharmaceutical company in the United States is the completion of FDA’s approval process. Over USD 50 billion is being spent on R&D in the country, annually. Interestingly, only one in 5000 drugs makes it to the market, leading to huge financial burden on drug manufacturing companies. The reason for this failure is the lack of accurate pre-clinical testing methods. The drug, which passed the in-vitro and animal testing stages, stands a high chance of failing in clinical trials, forcing manufacturers to start from the beginning. Medical researchers in order to make the drug discovery process more reliable are seeking means to mimic the 3-dimensional human tissue environment. With the advent of 3D bioprinting, manufacturers will be able to reduce complications associated with human clinical trials of novel drugs, reducing the losses incurred during late stage failures and shortening the drug discovery time, thus, driving the market for this technology.
UNITED STATES TO HOLD MAJOR SHARE IN NORTH AMERICA
Despite advances in medicine and technology, increased awareness about organ donation and transplantation, the gap between supply and demand continues to widen in the country. The number of people on the national waiting list continue to grow, while rates of donation and transplant stagnate. Currently, there are about 122,480 people in the waiting list in need of a lifesaving transplant, whereas, only 20,704 transplants were performed in 2016. It is estimated that on an average 22 people die each day while waiting for a transplant. 3D bioprinting is observed as the most promising solution to meet high demand for suitable organs for transplantation, driving the growth of the market in the region. In addition, the cost of organ transplantation is very high. The estimated average cost for heart, liver, and kidney transplants, are about USD 997,000, USD 577,000, and USD 262,000, respectively. Researchers are focusing on 3D bioprinting, which is seen as a viable alternative, which will help in driving the market.
Major Key Players: 3D Systems, Aspect Biosystems, Gesim, Bio3d, Organovo Holdings Inc.
Order a Copy Of 3D Bioprinting Market Report @https://www.360marketupdates.com/purchase/12883692
Reasons to Purchase 3D Bioprinting Market Report:
- Identification of key factors instrumental in changing the market scenario, exploiting new opportunities, and gaining a competitive edge.
- Analysing various perspectives of the market with the help of Porter’s five forces analysis.
- The authentication mode is likely to witness the highest adoption of these systems in the market.
- The regions that are expected to witness the fastest growth during the forecast period.
- The SWOT analysis for key players and a detailed study of their current strategic interests and key financial performance indicators.
- 3 months analyst support along with the Market Estimate sheet (in excel).
- This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
About 360 Market Updates:
360 Market Updates is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Market Updates, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.
Name: Mr. Ajay More
Email: [email protected]
Phone: +14242530807/+44 203 239 8187